Health Catalyst, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $132.5M
- Price
- $1.76
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.56%
- Volume
- 240.7K
About
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Quick stats
Shares outstanding75.3M
Computed float58.3M
Float / shares77.5%
Key info
SectorHealthcare
IndustryMedical - Healthcare Information Services
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001636422
AI Summary
AI-generated1/22
standardneutralexecutive change
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Health Catalyst's Compensation Committee granted incoming CEO Simeon Kohl 2,747,385 restricted stock units under the 2026 Employment Inducement Incentive Plan, tied to his appointment as Chief Executive Officer and President effective September 14, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).
Of the grant, 915,975 RSUs vest on September 14, 2027, with the remainder vesting in eight approximately equal quarterly installments, all contingent on Mr. Kohl's continued employment.
Separately, Mr. Kohl purchased an aggregate 59,000 Health Catalyst shares in open-market transactions on September 11 and 14, 2026 at a weighted average price of $1.787188 per share — a direct, if modest, show of confidence at a deeply depressed share price.
The inducement grant is dilutive if fully vested, and investor focus now shifts to turnaround execution and strategic direction under the new CEO.
Red flags
- 2.75M-RSU inducement grant is large in absolute terms and dilutive to existing holders if fully vested
- CEO's open-market purchase price of ~$1.79/share indicates the stock is trading at deeply depressed levels